NLRP3 inflammasome activation increases brain oxidative stress after transient global cerebral ischemia in rats

References

• Xu S, Lu J, Shao A, et al. Glial cells: role of the immune response in ischemic stroke. Front Immunol. 2020;11:294.
   PubMed Web of Science ®Google Scholar
• Phipps MS, Cronin CA. Management of acute ischemic stroke. BMJ. 2020;368:I6983.
   PubMed Web of Science ®Google Scholar
• Bustamante A, Giralt D, García-Berrocoso T, et al. The impact of post-stroke complications on in-hospital mortality depends on stroke severity. Eur Stroke J. 2017;2(1):54–63.
   PubMed Web of Science ®Google Scholar
• Patiño P, Parada E, Farré-Alins V, et al. Melatonin protects against oxygen and glucose deprivation by decreasing extracellular glutamate and nox-derived ROS in rat hippocampal slices. NeuroToxicology. 2016;57(December):61–68.
   PubMed Web of Science ®Google Scholar
• Shen J, Rastogi R, Geng X, et al. Nicotinamide adenine dinucleotide phosphate oxidase activation and neuronal death after ischemic stroke. Neural Regen Res. 2019;14(6):948.
   PubMed Web of Science ®Google Scholar
• Rayasam A, Hsu M, Kijak JA, et al. Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures?Immunology. 2018;154(3):363–376.
   PubMed Web of Science ®Google Scholar
• Alawieh A, Langley EF, Tomlinson S. Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice. Sci Transl Med. 2018;10(441):eaao6459.
   PubMed Web of Science ®Google Scholar
• Jayaraj RL, Azimullah S, Beiram R, et al. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142.
   PubMed Web of Science ®Google Scholar
• Li P, Stetler RA, Leak RK, et al. Oxidative stress and DNA damage after cerebral ischemia: potential therapeutic targets to repair the genome and improve stroke recovery. Neuropharmacology. 2018;134:208–217.
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Fernandez-Gajardo R, Gutierrez R, et al. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets. 2013;12(5):698–714.
   PubMed Web of Science ®Google Scholar
• Ye Y, Jin T, Zhang X, et al. Meisoindigo protects against focal cerebral ischemia-reperfusion injury by inhibiting NLRP3 inflammasome activation and regulating microglia/macrophage polarization via TLR4/NF-ΚB signaling pathway. Front Cell Neurosci. 2019;13(December):553.
   PubMed Web of Science ®Google Scholar
• Chen A, Xu Y, Yuan J. Ginkgolide B ameliorates NLRP3 inflammasome activation after hypoxic-ischemic brain injury in the neonatal male rat. Int J Dev Neurosci. 2018;69(October):106–111.
   PubMed Web of Science ®Google Scholar
• Zoete MR, de NW, Palm S, et al. Inflammasomes. Cold Spring Harb Perspect Biol. 2014;6(12):a016287.
   PubMed Web of Science ®Google Scholar
• Thakkar R, Wang R, Sareddy G, et al. NLRP3 inflammasome activation in the brain after global cerebral ischemia and regulation by 17β-estradiol. Oxid Med Cell Longev. 2016;2016:8309031.
   PubMed Web of Science ®Google Scholar
• Ma C, Liu S, Zhang S, et al. Evidence and perspective for the role of the NLRP3 inflammasome signaling pathway in ischemic stroke and its therapeutic potential (review). Int J Mol Med. 2018;42(6):2979–2990.
   PubMed Web of Science ®Google Scholar
• Abderrazak A, Syrovets T, Couchie D, et al. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol. 2015;4:296–307.
   PubMed Web of Science ®Google Scholar
• Morris G, Walker AJ, Berk M, et al. Cell death pathways: a novel therapeutic approach for neuroscientists. Mol Neurobiol. 2018;55(7):5767–5786.
   PubMed Web of Science ®Google Scholar
• Hong P, Gu RN, Li FX, et al. NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes. J Neuroinflammation. 2019;16(1):121.
   Web of Science ®Google Scholar
• Bonfante S, Della Giustina A, Danielski L, et al. Stanniocalcin-1 ameliorates cerebral ischemia by decrease oxidative stress and blood brain barrier permeability. Microvasc Res. 2020;128:103956.
   PubMed Web of Science ®Google Scholar
• Bu F, Munshi Y, Furr JW, et al. Activation of neuronal Ras-related C3 botulinum toxin substrate 1 (Rac1) improves post-stroke recovery and axonal plasticity in mice. J Neurochem. 2020;22. DOI:10.1111/jnc.15195.
   PubMed Web of Science ®Google Scholar
• Rathore P, Arora I, Rastogi S, et al. Collagen nanoparticle-mediated brain silymarin delivery: an approach for treating cerebral ischemia and reperfusion-induced brain injury. Front Neurosci. 2020;14(October):538404.
   PubMed Web of Science ®Google Scholar
• Eliot L, Richardson SS. Sex in context: limitations of animal studies for addressing human sex/gender neurobehavioral health disparities. J Neurosci. 2016;36(47):11823–11830.
   PubMed Web of Science ®Google Scholar
• Soleimannejad K, Rahmani A, Hatefi M, et al. Effects of Nigella sativa extract on markers of cerebral angiogenesis after global ischemia of brain in rats. J Stroke Cerebrovasc Dis. 2017;26(7):1514–1520.
   PubMed Web of Science ®Google Scholar
• Dempsey C, Rubio Araiz A, Bryson KJ, et al. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. Brain Behav Immun. 2017;61(March):306–316.
   PubMed Web of Science ®Google Scholar
• Young LM, De JB, Kheifets SJ, et al. Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents. Agents Actions. 1989;26(3–4):335–341.
   PubMedGoogle Scholar
• Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and 15N nitrate in biological fluids. Anal Biochem. 1982;126(1):131–138.
   PubMed Web of Science ®Google Scholar
• Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421–431.
   PubMed Web of Science ®Google Scholar
• Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–478.
   PubMed Web of Science ®Google Scholar
• Bannister JV, Calabrese L. Assays for superoxide dismutase. Methods Biochem Anal. 1987;32:279–312.
   PubMedGoogle Scholar
• Aebi H. 13 Catalase in vitro. Methods Enzymol. 1984;105(C):121–126.
   PubMed Web of Science ®Google Scholar
• Chen JP. Production of ethyl butyrate using gel-entrapped candida cylindracea lipase. J Ferment Bioeng. 1996;82(4):404–407.
   Google Scholar
• Boese AC, Lee JP, Hamblin MH. Neurovascular protection by peroxisome proliferator-activated receptor α in ischemic stroke. Exp Neurol. 2020;331:113323.
   PubMed Web of Science ®Google Scholar
• Jickling GC, Liu DZ, Ander BP, et al. Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab. 2015;35(6):888–901.
   PubMed Web of Science ®Google Scholar
• Ehlers MR, Todd RM. Genesis and maintenance of attentional biases: the role of the locus coeruleus-noradrenaline system. Neural Plast. 2017;1(1):2–3.
   Google Scholar
• Matsuo Y, Onodera H, Shiga Y, et al. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat: effects of neutrophil depletion. Stroke. 1994;25(7):1469–1475.
   PubMed Web of Science ®Google Scholar
• Pravalika K, Sarmah D, Kaur H, et al. Trigonelline therapy confers neuroprotection by reduced glutathione mediated myeloperoxidase expression in animal model of ischemic stroke. Life Sci. 2019;216(January):49–58.
   PubMed Web of Science ®Google Scholar
• Saad MAEL, Fahmy MIM, Al-Shorbagy M, et al . Nateglinide exerts neuroprotective effects via downregulation of HIF-1α/TIM-3 inflammatory pathway and promotion of caveolin-1 expression in the rat’s hippocampus subjected to focal cerebral ischemia/reperfusion injury. Inflammation. 2020;43(2):401–416.
   PubMed Web of Science ®Google Scholar
• Mizushina Y, Shirasuna K, Usui F, et al. NLRP3 protein deficiency exacerbates hyperoxia-induced lethality through stat3 protein signaling independent of interleukin-1β. J Biol Chem. 2015;290(8):5065–5077.
   PubMed Web of Science ®Google Scholar
• Guo Z, Yu S, Chen X, et al. Suppression of NLRP3 attenuates hemorrhagic transformation after delayed RtPA treatment in thromboembolic stroke rats: involvement of neutrophil recruitment. Brain Res Bull. 2018;137(March):229–240.
   PubMed Web of Science ®Google Scholar
• Gao L, Dong Q, Song Z, et al. NLRP3 inflammasome: a promising target in ischemic stroke. Inflamm Res. 2017;66(1):17–24.
   PubMed Web of Science ®Google Scholar
• Groslambert M, Py BF. Spotlight on the NLRP3 inflammasome pathway. J Inflamm Res. 2018;11:359–374.
   PubMed Web of Science ®Google Scholar
• Kelley N, Jeltema D, Duan Y, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328.
   PubMed Web of Science ®Google Scholar
• Vajjhala PR, Mirams RE, Hill JM. Multiple binding sites on the pyrin domain of ASC protein allow self-association and interaction with NLRP3 protein. J Biol Chem. 2012;287(50):41732–41743.
   PubMed Web of Science ®Google Scholar
• Duncan JA, Bergstralh DT, Wang Y, et al. Cryopyrin/NALP3 binds ATP/DATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc Natl Acad Sci USA. 2007;104(19):8041–8046.
   PubMed Web of Science ®Google Scholar
• Coll RC, Hill JR, Day CJ, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15(6):556–559.
   PubMed Web of Science ®Google Scholar
• Liu H, Wu X, Luo J, et al. Adiponectin peptide alleviates oxidative stress and NLRP3 inflammasome activation after cerebral ischemia-reperfusion injury by regulating AMPK/GSK-3β. Exp Neurol. 2020;329:113302.
   PubMed Web of Science ®Google Scholar
• Giustarini D, Rossi R, Milzani A, et al. Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. Methods Enzymol. 2008;440:361–380.
   PubMed Web of Science ®Google Scholar
• Narne P, Pandey V, Phanithi PB. Role of nitric oxide and hydrogen sulfide in ischemic stroke and the emergent epigenetic underpinnings. Mol Neurobiol. 2019;56(3):1749–1769.
   PubMed Web of Science ®Google Scholar
• Nash KM, Schiefer IT, Shah ZA. Development of a reactive oxygen species-sensitive nitric oxide synthase inhibitor for the treatment of ischemic stroke. Free Radic Biol Med. 2018;115(February):395–404.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463–477.
   PubMed Web of Science ®Google Scholar
• Szabó C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov. 2007;6(8):662–680.
   PubMed Web of Science ®Google Scholar
• Abais JM, Xia M, Zhang Y, et al. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid Redox Signal. 2015;22(13):1111–1129.
   Google Scholar
• Hewinson J, Moore SF, Glover C, et al . A key role for redox signaling in rapid P2X7 receptor-induced IL-1 beta processing in human monocytes. J Immunol. 2008;180(12):8410–8420.
   PubMed Web of Science ®Google Scholar
• Bossy-Wetzel E, Talantova MV, Lee WD, et al. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and P38-activated K+ channels. Neuron. 2004;41(3):351–365.
   PubMed Web of Science ®Google Scholar
• Jiang XC, Xiang JJ, Wu HH, et al. Neural stem cells transfected with reactive oxygen species–responsive polyplexes for effective treatment of ischemic stroke. Adv Mater. 2019;31(10):1807591.
   Web of Science ®Google Scholar
• Collin F. Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases. Int J Mol Sci. 2019;20(10):2407.
   PubMed Web of Science ®Google Scholar
• Sun M-S, Jin H, Sun X, et al. Free radical damage in ischemia-reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy. Oxid Med Cell Longev. 2018;2018:3804979.
   PubMed Web of Science ®Google Scholar
• Möller MN, Cuevasanta E, Orrico F, et al. Diffusion and transport of reactive species across cell membranes. Adv Exp Med Biol. 2019;1127:3–19.
   Google Scholar
• Bertrand L, Dygert L, Toborek M. Induction of ischemic stroke and ischemia-reperfusion in mice using the middle artery occlusion technique and visualization of infarct area. J Vis Exp. 2017;2017(120):54805.
   PubMedGoogle Scholar
• Ismael S, Zhao L, Nasoohi S, et al. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep. 2018;8(1):5971.
   PubMed Web of Science ®Google Scholar
• Ward R, Li W, Abdul Y, et al. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. Pharmacol Res. 2019;142(April):237–250.
   PubMed Web of Science ®Google Scholar
• Wang H, Chen H, Jin J, et al. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion. Life Sci. 2020;251(June):117638.
   PubMed Web of Science ®Google Scholar
• Shirle R, Ord ENJ, Work LM. Oxidative stress and the use of antioxidants in stroke. Antioxidants (Basel). 2014;3(3):472–501.
   PubMedGoogle Scholar
• Zorina II, Fokina EA, Zakharova IO, et al. Features of the changes in lipid peroxidation and activity of Na+/K+-ATPase in the brain of the aged rats in the conditions of two-vessel cerebral ischemia/reperfusion. Adv Gerontol. 2019;32(6):941–947.
   PubMedGoogle Scholar
• Neves Carvalho A, Firuzi O, Gama MJ, et al. Oxidative stress and antioxidants in neurological diseases: is there still hope?Curr Drug Targets. 2017;18(6):705–718.
   PubMed Web of Science ®Google Scholar
• Glorieux C, Calderon PB. Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach. Biol Chem. 2017;398(10):1095–1108.
   PubMed Web of Science ®Google Scholar
• Fukai T, Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal. 2011;15(6):1583–1606.
   PubMed Web of Science ®Google Scholar
• Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015;97:55–74.
   PubMed Web of Science ®Google Scholar
• Yang Q, Li S, Zhou Z, et al. HDAC6 inhibitor cay10603 inhibits high glucose-induced oxidative stress, inflammation and apoptosis in retinal pigment epithelial cells via regulating NF-ΚB and NLRP3 inflammasome pathway. Gen Physiol Biophys. 2020;39(2):169–177.
   PubMed Web of Science ®Google Scholar